Menu
 
Research menu
Jump to menu

Publications:  Dr Stephanie Kermorgant

Barrow-McGee R, Kishi N, Joffre C et al.(2016). Corrigendum: Beta 1-integrin-c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes. Nat Commun vol. 7, 12392-12392.
10.1038/ncomms12392
BRENNAN CH(2016). Beta 1-integrin–c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes. Nature Communications vol. 7, 11942-11942.
10.1038/ncomms11942
http://qmro.qmul.ac.uk/xmlui/handle/123456789/13178
Barrow-McGee R, Kishi N, Joffre C et al.(2016). Beta 1-integrin–c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes. Nature Communications vol. 7, 11942-11942.
10.1038/ncomms11942
http://qmro.qmul.ac.uk/xmlui/handle/123456789/13178
Mofta H, Dias K, Hoque Apu E et al.(2016). Desmoglein 3 regulates membrane trafficking of cadherins, an implication in cell-cell adhesion. Cell Adhesion & Migration
10.1080/19336918.2016.1195942
http://qmro.qmul.ac.uk/xmlui/handle/123456789/17654
Moftah H, Dias K, Apu EH et al.(2016). Desmoglein 3 regulates membrane trafficking of cadherins, an implication in cell-cell adhesion. Cell Adhesion and Migration1-22.
10.1080/19336918.2016.1195942
http://qmro.qmul.ac.uk/xmlui/handle/123456789/17654
Hervieu A, Kermorgant S(2015). PI3K class I and mTOR regulate distinct steps in Met dependent tumorigenesis. MOLECULAR CANCER THERAPEUTICS vol. 14, (7)
10.1158/1538-8514.PI3K14-B26
Ho-Yen CM, Jones JL, Kermorgant S(2015). The clinical and functional significance of c-Met in breast cancer: a review. Breast Cancer Res vol. 17,
10.1186/s13058-015-0547-6
http://qmro.qmul.ac.uk/xmlui/handle/123456789/15970
Moftah H, Diaz K, Kermorgant S et al. (2014). Role for Desmoglein 3 in regulating E-cadherin trafficking. JOURNAL OF INVESTIGATIVE DERMATOLOGY. vol. 134, S29-S29.
Hervieu A, Joffre C, Leung Z et al.(2014). Understanding and targeting PI3K pathway downstream of Met oncogenic mutant. EUROPEAN JOURNAL OF CANCER vol. 50, S115-S115.
10.1016/S0959-8049(14)50424-8
Ménard L, Parker PJ, Kermorgant S(2014). Receptor tyrosine kinase c-Met controls the cytoskeleton from different endosomes via different pathways. Nat Commun vol. 5,
10.1038/ncomms4907
Mai A, Muharram G, Barrow-McGee R et al.(2014). Distinct c-Met activation mechanisms induce cell rounding or invasion through pathways involving integrins, RhoA and HIP1. J Cell Sci vol. 127, (Pt 9) 1938-1952.
10.1242/jcs.140657
Barrow-McGee R, Kermorgant S(2014). Met endosomal signalling: In the right place, at the right time. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY vol. 49, 69-74.
10.1016/j.bioce1.2014.01.009
Barrow-McGee R, Kermorgant S(2014). Met endosomal signalling: in the right place, at the right time. Int J Biochem Cell Biol vol. 49, 69-74.
10.1016/j.biocel.2014.01.009
Ho-Yen CM, Green AR, Rakha EA et al.(2014). C-Met in invasive breast cancer: is there a relationship with the basal-like subtype?. Cancer vol. 120, (2) 163-171.
10.1002/cncr.28386
Barrow R, Joffre C, Ménard L et al.(2014). Measuring the role for Met endosomal signaling in tumorigenesis. Methods Enzymol vol. 535, 121-140.
10.1016/B978-0-12-397925-4.00008-0
Radtke S, Milanovic M, Rossé C et al.(2013). ERK2 but not ERK1 mediates HGF-induced motility in non-small cell lung carcinoma cell lines. J Cell Sci vol. 126, (Pt 11) 2381-2391.
10.1242/jcs.115832
Ho-Yen C, Bowen RL, Kermorgant S et al.(2013). Comment on 'High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer'. Br J Cancer vol. 108, (10) 2195-2196.
10.1038/bjc.2013.249
http://qmro.qmul.ac.uk/xmlui/handle/123456789/15971
Ho-Yen C, Green A, Ellis I et al. (2012). C-Met Expression Correlates with Molecular Sub-type and Outcome in Invasive Breast Cancer. JOURNAL OF PATHOLOGY. vol. 228, S16-S16.
Milanovic M, Radtke S, Peel N et al.(2012). Anomalous inhibition of c-Met by the kinesin inhibitor aurintricarboxylic acid. Int J Cancer vol. 130, (5) 1060-1070.
10.1002/ijc.26066
Bowen RL, Ho-Yen C, Vaziri R et al. (2011). C-met Defines a Distinct Subset of Triple Negative Breast Cancer in British Black Women. JOURNAL OF PATHOLOGY. vol. 224, S21-S21.
Joffre C, Barrow R, Ménard L et al.(2011). A direct role for Met endocytosis in tumorigenesis. Nat Cell Biol vol. 13, (7) 827-837.
10.1038/ncb2257
Reynolds LE, Watson AR, Baker M et al.(2010). Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome (vol 465, pg 813, 2010). NATURE vol. 466, (7304)
10.1038/nature09281
Reynolds LE, Watson AR, Baker M et al.(2010). Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome. Nature vol. 465, (7299) 813-817.
10.1038/nature09106
http://qmro.qmul.ac.uk/xmlui/handle/123456789/9886
Kermorgant S, Nevo J, Ivaska J(2010). Smart targeting of EGFR in lung cancer. PHARMACOGENOMICS vol. 11, (6) 743-744.
10.2217/pgs.10.78
Barrow R, Menard L, Kermorgant S (2010). c-Met endosomal signalling and breast cancer cell migration. EJC SUPPLEMENTS. vol. 8, 116-116.
10.1016/S1359-6349(10)71255-6
Rosse C, Linch M, Kermorgant S et al.(2010). PKC and the control of localized signal dynamics. Nat Rev Mol Cell Biol vol. 11, (2) 103-112.
10.1038/nrm2847
Kermorgant S, Parker PJ(2008). Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation. J Cell Biol vol. 182, (5) 855-863.
10.1083/jcb.200806076
http://qmro.qmul.ac.uk/xmlui/handle/123456789/15969
Aparicio T, Kermorgant S, Darmoul D et al.(2005). Leptin and Ob-Rb receptor isoform in the human digestive tract during fetal development. J CLIN ENDOCR METAB vol. 90, (11) 6177-6184.
10.1210/jc.2005-1498
Kermorgant S, Parker PJ(2005). c-met signalling - Spatio-temporal decisions. CELL CYCLE vol. 4, (3) 352-355.
10.4161/cc.4.3.1596
Kermorgant S, Zicha D, Parker PJ(2004). PKC controls HGF-dependent c-Met traffic, signalling and cell migration. EMBO J vol. 23, (19) 3721-3734.
10.1038/sj.emboj.7600396
Casamassima A, Durgan J, Iturrioz X et al. (2004). PKC superfamily - localised action and complex assembly. FASEB JOURNAL. vol. 18, C122-C122.
Kermorgant S, Zicha D, Parker PJ(2003). Protein kinase C controls microtubule-based traffic but not proteasomal degradation of c-Met. J Biol Chem vol. 278, (31) 28921-28929.
10.1074/jbc.M302116200
Ivaska J, Kermorgant S, Whelan R et al.(2003). Integrin-protein kinase C relationships. Biochem Soc Trans vol. 31, (Pt 1) 90-93.
10.1042/bst0310090
Walker F, Kermorgant S, Daraï E et al.(2003). Hepatocyte growth factor and c-Met in cervical intraepithelial neoplasia: overexpression of proteins associated with oncogenic human papillomavirus and human immunodeficiency virus. Clin Cancer Res vol. 9, (1) 273-284.
Kermorgant S, Dessirier V, Lewin MJM et al.(2002). HGF upregulates and modifies subcellular distribution of proteins in colon cancer cell enterocytic differentiation (vol 281, pg G1068, 2001). AM J PHYSIOL-GASTR L vol. 282, (3) GA2-GA2.
Goïot H, Attoub S, Kermorgant S et al.(2001). Antral mucosa expresses functional leptin receptors coupled to STAT-3 signaling, which is involved in the control of gastric secretions in the rat. Gastroenterology vol. 121, (6) 1417-1427.
10.1053/gast.2001.29581
Kermorgant S, Dessirier V, Lewin MJ et al.(2001). HGF upregulates and modifies subcellular distribution of proteins in colon cancer cell enterocytic differentiation. Am J Physiol Gastrointest Liver Physiol vol. 281, (4) G1068-G1080.
10.1152/ajpgi.2001.281.4.G1068
Kermorgant S, Lehy T(2001). Glycine-extended gastrin promotes the invasiveness of human colon cancer cells. BIOCHEM BIOPH RES CO vol. 285, (1) 136-141.
10.1006/bbrc.2001.5132
Kermorgant S, Aparicio T, Dessirier V et al.(2001). Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for PI3 kinase and PKC involvement. Carcinogenesis vol. 22, (7) 1035-1042.
10.1093/carcin/22.7.1035
Return to top